Megan Molteni, STAT

Megan Molteni

STAT

Minneapolis, MN, United States

Contact Megan

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

Recent:
  • Unknown
Past:
  • STAT

Past articles by Megan:

With CRISPR cures on horizon, sickle cell patients ask hard questions about who can access them

With CRISPR cures for sickle cell disease on the horizon, the gene-editing world must grapple with tough questions of equity and access. → Read More

At genome-editing summit, experts worry that rule changes on embryo research in China fall short

Nearly a dozen Chinese laws addressing human genome editing have been written or refined, but experts at an international conference worried the changes are insufficient. → Read More

CRISPR patent fight redux? A new battle is brewing among biotechs over next-gen gene-editing tools

The next CRISPR gene-editing patent war might look quite different; it's shaping up to be a free-for-all among a multitude of companies and labs. → Read More

Its founder hopes to reverse aging, but first Tally Health wants to test how fast your biological clock ticks

Tally Health, a company Harvard's David Sinclair has been building since 2021, officially launched to sell epigenetic clock tests to the chrono-curious. → Read More

After bullying allegations, Eric Lander will return to run a lab at the Broad Institute

After resigning as White House science adviser over bullying allegations, Eric Lander is returning to the Broad Institute and faculty posts at MIT and Harvard. → Read More

Eric Lander’s next act: leading a nonprofit set on solving thorny scientific challenges

Lander’s latest project is leading a new nonprofit called Science for America, with a mission to serve as a “solutions incubator” for pressing problems facing the world. → Read More

In a first, children with rare genetic diseases get mitochondrial transplants from their mothers

Mitochondrial augmentation therapy could provide a way to treat not just rare genetic diseases, but other conditions and injuries arising from mitochondrial damage. → Read More

‘Make People Better’: The CRISPR babies story you probably don’t know, and how it was filmed in real-time

"Make People Better," now streaming, offers a ride-along on the most explosive science story of the 21st century: the CRISPR babies scandal. → Read More

New concerns about a paper co-authored by Stanford president prompt journal to take a 'closer look'

A scientific integrity expert who specializes in identifying manipulated images identified significant alterations in an image in a Cell paper that appeared to have been intentional. → Read More

'This actually changes everything': Altered image in 1999 paper raises potential peril for Stanford president

New findings of altered images in research co-authored by Stanford University president Marc Tessier-Lavigne add to the weight of allegations against him, according to experts on research misconduct. → Read More

On the long road to treating Huntington's genetic stutter, scientists return to overlooked clues

After the recent failure of four Huntington's therapies, researchers increasingly believe the drug industry has been stymied by an incomplete understanding of the disease. → Read More

After three years in prison, ‘CRISPR babies’ scientist is attempting a comeback

A flurry of activity on social media platforms makes it clear that He Jiankui is eager to re-enter public life and has every intention of rejoining the race toward scientific progress. → Read More

PACT Pharma’s personalized cancer treatments, powered by CRISPR, clear early safety hurdles

PACT Pharma and UCLA researchers infused individualized cocktails of CRISPR-edited immune cells into 16 cancer patients with minimal and manageable side effects. → Read More

Brain implants that translate paralyzed patients’ thoughts into speech creep closer to reality

In a new study, a brain implant was able to decode more than 1,100 words from the electrical activity inside a paralyzed patient's brain as he silently tried saying the letters. → Read More

A new suite of RNA-sensing tools could help scientists target cancerous cells, and much more

New RNA-sensing tools could allow scientists to deliver therapeutic payloads, like CRISPR, exclusively to specific types of cells. → Read More

Got questions about the timing of flu and Covid vaccines? Here’s what experts say

With the third Covid winter approaching amid an early flu season, experts agree that the best time to get vaccinated is now, before these viral ripples build into waves. → Read More

Human neurons implanted in a rodent’s brain lead a rat to water — and make it drink

The experiment is the first describing human neurons influencing another species’ behavior. The study also showed that signals could go the other way. → Read More

Nobel Prize in medicine awarded for research into the evolutionary history of humankind

Swedish scientist Svante Pääbo won the 2022 Nobel Prize in medicine or physiology on Monday for his groundbreaking research into the evolutionary history of humankind. → Read More

Who will get the call from Stockholm? It’s time for STAT’s 2022 Nobel Prize predictions

The shortlist of possible Nobel Prize winners this year in science and medicine includes researchers who elucidated how cells make energy and discovered the chemical chatter of bacteria, and the pioneers behind Covid mRNA vaccines. → Read More

10 key questions about monkeypox the world needs to answer

Monkeypox is not a new disease. But scant attention paid to it for decades means there are big unanswered questions about the disease and the virus that causes it. → Read More